Suchergebnisse - "Sleeboom-Faulkner, Margaret"

PubPharm (79)

1

Downgrading of regulation in regenerative medicine

enthalten in: Science (New York, N.Y.) | 2019

von Sipp, D. | Sleeboom-Faulkner, M.

2

Regulatory brokerage : Competitive advantage and regulation in the field of regenerative medicine

enthalten in: Social studies of science | 2019

von Sleeboom-Faulkner, M.

3

Heritable Genome Editing in a Global Context : National and International Policy Challenges

enthalten in: The Hastings Center report | 2019

von Rosemann, A. | Balen, A. | Nerlich, B. | +5

CommentIn: Hastings Cent Rep. 2019 May;49(3):43-44. - PMID 31269259

4

Heritable Genome Editing in a Global Context : National and International Policy Challenges

enthalten in: Hastings Center Report | 2019

von Rosemann, A. | Balen, A. | Nerlich, B. | +5

5

The justification of studies in genetic epidemiology - political scaling in China Medical City

enthalten in: Anthropology & medicine | 2018

von Sleeboom-Faulkner, M.

6

Genomics and genetic medicine : pathways to global health?

enthalten in: Anthropology & medicine | 2018

von Gibbon, S. | Kilshaw, S. | Sleeboom-Faulkner, M.

7

Marketing of unproven stem cell-based interventions : A call to action

enthalten in: Science translational medicine | 2017

von Sipp, D. | Caulfield, T. | Kaye, J. | +12

8

Global regulatory developments for clinical stem cell research : diversification and challenges to collaborations

enthalten in: Regenerative medicine | 2016

von Rosemann, A. | Bortz, G. | Vasen, F. | +1

9

Comparing national home-keeping and the regulation of translational stem cell applications : An international perspective

enthalten in: Social science & medicine (1982) | 2016

von Sleeboom-Faulkner, M. | Chekar, C. | Faulkner, A. | +12

10

New regulation for clinical stem cell research in China : expected impact and challenges for implementation

enthalten in: Regenerative medicine | 2016

von Rosemann, A. | Sleeboom-Faulkner, M.

1
2
3
4
5
6
7
8
Nächster »
[8]